Personalized Decision Support in Type 2 Diabetes Mellitus: Current Evidence and Future Directions
- 466 Downloads
The management of type 2 diabetes comprises a complex series of medical decisions regarding goals of care, self-care behaviors, and medical treatments. The quality of these medical decisions is critical to determining whether an individual diabetes patient is treated appropriately, overtreated, or undertreated. It is hypothesized that the quality of these medical decisions can be enhanced by personalized decision support tools that summarize patient clinical characteristics, treatment preferences, and ancillary data at the point of care. We describe the current state of personalized diabetes decision support on the basis of 13 recently described tools. Three tools provided support for personalized decisions based on preferences, while the remaining 10 provided support for treatment decisions designed to achieve standard diabetes goals. For the tools that supported personalized decisions, patient participation in medical decisions improved. Future decision support tools must be designed to account for both clinical characteristics and patient preferences.
KeywordsType 2 diabetes mellitus Decision support Decision support tool Decision aid Personalized decision support
Conflicts of interest: M. J. Wilkinson, none; A. G. Nathan has received grant support from Retirement Research Foundation and the American Diabetes Association; E.S. Huang has received grant support from Retirement Research Foundation, the American Diabetes Association (Clinical Research Award), and the NIDDK (NIDDK P30 DK092949-01).
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 1.Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012;35:1364–79.PubMedCrossRefGoogle Scholar
- 3.American Diabetes Association. Executive summary: standards of medical care in diabetes--2012. Diabetes Care. 2012;35 Suppl 1:S4–S10.Google Scholar
- 9.Stacey D, Bennett CL, Barry MJ, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2011;CD001431.Google Scholar
- 11.•• Mullan RJ, Montori VM, Shah ND, et al. The diabetes mellitus medication choice decision aid. Arch Intern Med. 2009;169:1560–8. This article describes use of a personalized decision support tool that considered patient preferences in treatment decisions. Its use increased patient involvement, as well as aspects of knowledge and acceptability.PubMedCrossRefGoogle Scholar
- 15.•• Mann DM, Ponieman D, Montori VM, et al. The Statin Choice decision aid in primary care: a randomized trial. Patient Educ Couns. 2010;80:138–40. This article describes recent use of the Statin Choice tool, an important example of a personalized decision support tool that considers patient preferences in treatment decisions.PubMedCrossRefGoogle Scholar
- 18.Hunt JS, Siemienczuk J, Gillanders W, et al. The impact of a physician-directed health information technology system on diabetes outcomes in primary care: a pre- and post-implementation study. Informat Prim Care. 2009;17:165–74.Google Scholar
- 25.• Rodbard D, Vigersky RA. Design of a decision support system to help clinicians manage glycemia in patients with type 2 diabetes mellitus. J Diabetes Sci Technol. 2011;5:402–11. From the perspective of personalization, this article is important because the tool allows physicians to set hemoglobin A1c and other glycemia goals. This introduces the potential for personalization, if physicians using the tool set glycemic goals on the basis of a consideration of patient clinical factors or preferences.PubMedGoogle Scholar